CDKN2A and neoplasm: In contrast, we observed a strong cytoplasmic expression of P16 in the highly dysplastic region of the CDKN2AWT/#KRASG12DPDAC-like tumor resulting in tumor growth restriction suggesting partial compensation by the heterozygous CDKN2A WT allele upon high oncogenic burden.